The Global Online Sexuality Survey (GOSS): The United States of America in 2011 Chapter II: Phosphodiesterase Inhibitors Utilization among English Speakers
Author:
Publisher
Elsevier BV
Subject
Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health
Reference18 articles.
1. A multicenter, randomized, double‐blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction;Govier;Clin Ther,2003
2. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction;Mulhall;J Sex Med,2005
3. Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: The proper drug for the proper patient;Corona;J Sex Med,2011
4. Patient preference and satisfaction in erectile dysfunction therapy: A comparison of the three phosphodiesterase‐5 inhibitors sildenafil, vardenafil and tadalafil;Raheem;Patient Prefer Adherence,2009
5. Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long‐term treatment compliance;Ljunggren;J Sex Med,2008
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association of sildenafil use with age-related macular degeneration: a retrospective cohort study;BMJ Open Ophthalmology;2024-03
2. Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis;Sexual Medicine;2023-10-01
3. Recreational use of oral erectile dysfunction medications among male physicians - A cross-sectional study;Urology Annals;2023
4. Use of phosphodiesterase-5 inhibitors and the incidence of melanoma;Cancer Epidemiology;2022-12
5. A Modified Procedure to Diagnose Erectile Dysfunction Using the International Index of Erectile Function (IIEF-6) Combined With the Premature Ejaculation Diagnosis Tool (PEDT) via an Internet Survey;Sexual Medicine;2022-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3